Hepatitis C virus and death risk in hemodialysis patients.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2006070736PMID 17429053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6

  2006cited by this paper
• Hepatitis C inflection in dialysis patients: a link to poor clinical outcome?

  2006cited by this paper
• Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.

  2006cited by this paper
• Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region.

  2006cited by this paper
• Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients.

  2005cited by this paper
• Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study.

  2005cited by this paper
• Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.

  2005cited by this paper
• Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

  2005cited by this paper
• Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction.

  2005cited by this paper
• Time-dependent associations between iron and mortality in hemodialysis patients.

  2005cited by this paper
• Diagnostic discordance for hepatitis C virus infection in hemodialysis patients.

  2005cited by this paper
• Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center.

  2004cited by this paper
• Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences.

  2004influential reference
• Hepatitis C and renal disease: an update.

  2003influential reference
• Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

  2003cited by this paper
• Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.

  2003cited by this paper
• Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences.

  2003cited by this paper
• Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.

  2003cited by this paper
• Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.

  2003cited by this paper
• Hepatitis C Virus Core Protein Potentiates TNF-α-Induced NF-κB Activation through TRAF2-IKKβ-Dependent Pathway

  2001cited by this paper
• Hepatitis C Virus Seropositivity at the Time of Renal Transplantation in the United States: Associated Factors and Patient Survival

  2001cited by this paper
• Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway.

  2001cited by this paper
• Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD.

  2000cited by this paper
• Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy.

  2000cited by this paper
• The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study.

  2000influential reference
• Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.

  1999cited by this paper
• Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease1

  1998cited by this paper
• Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.

  1998cited by this paper
• Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.

  1998cited by this paper
• Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease

  1998cited by this paper
• Risk of death among chronic dialysis patients infected with hepatitis C virus.

  1998cited by this paper
• High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients.

  1997cited by this paper
• Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study.

  1995cited by this paper

• Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection

  2024cites this paper
• SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024

  2024cites this paper
• Hepatitis C and hepatitis B virus infection in hemodialysis patients after nationwide direct antiviral agents therapy—experience of 10 Romanian HD centers

  2023influential citation
• Underlying diseases, nutritional assessment, viral incidence and HBV immunity status in patients undergoing hemodialysis

  2023cites this paper
• Efficacy and Safety of Directly Acting Antivirals in Patients with Hepatitis C Infection on Hemodialysis.

  2023cites this paper
• Hepatitis C Seroconversion Remains High among Patients with Regular Hemodialysis: Study of Associated Risk Factors

  2022cites this paper
• Hepatitis C virus and kidney transplantation: Recent trends and paradigm shifts.

  2022cites this paper
• Frequency of chronic Hepatitis B and Hepatitis C seropositivity in haemodialysis patients; A single center study.

  2022cites this paper
• Aminotransferase-to-platelet ratio index and Fibrosis-4 index score predict hepatic fibrosis evaluated by transient hepatic elastography in hepatitis C virus-infected hemodialysis patients

  2021cites this paper
• Characteristics of ESRD Patients who have been on Long-term Hemodialysis Therapy in Egypt

  2021cites this paper
• The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis

  2021cites this paper
• Prevalence of hepatitis-C virus infection in non-dialysis CKD patients: a multicenter study in renal clinics.

  2021cites this paper
• The Efficacy and Safety of Sofosbuvir/Daclatasvir Fixed-Dose Combination in Iranian Hemodialysis Patients with Hepatitis C Virus Infection

  2021cites this paper
• Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis

  2021cites this paper
• An updated systematic review and meta-analysis on efficacy of Sofosbuvir in treating hepatitis C-infected patients with advanced chronic kidney disease.

  2021cites this paper
• Prevalence and risk factors for hepatitis b and c among end-stage renal disease patients on hemodialysis in Gaborone, Botswana

  2021cites this paper
• Low serum prealbumin concentration predicts long‐term mortality in maintenance hemodialysis patients with hepatitis B and/or C virus infections

  2021cites this paper
• Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study

  2021cites this paper
• Diagnostic Accuracy of Non-Invasive Tests to Detect Advanced Hepatic Fibrosis in Patients With Hepatitis C and End-Stage Renal Disease.

  2020cites this paper
• The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C

  2020cites this paper
• Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and decompensated cirrhosis: a case series

  2020cites this paper
• Hepatitis C virus infection and global kidney health: the consensus proceedings of the International Federation of Kidney Foundations.

  2020cites this paper
• Differences between the Incident and Prevalent Hemodialysis Patients in Egypt

  2020cites this paper
• Incidence of Acute Kidney Injury in HCV Infected Patients Receiving Direct-Acting Antivirals

  2020cites this paper
• Eighteen‐year follow‐up cohort study on hepatitis B and C virus infections related long‐term prognosis among hemodialysis patients in Hiroshima

  2020cites this paper
• A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment

  2019influential citation
• The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study

  2019cites this paper
• Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

  2019cites this paper
• Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection

  2019cites this paper
• BURDEN OF HEPATITIS B AND HEPATITIS C VIRUS IN HAEMODIALYSIS PATIENTS

  2019cites this paper
• Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study

  2019cites this paper
• ORIGINAL RESEARCH PAPER HEPATITIS C VIRUS ANTIBODIES AMONG HEMODIALYSIS PATIENTS IN MAKKAH CITY, KINGDOM OF SAUDI ARABIA

  2019cites this paper
• Clinical outcomes of hepatitis C virus elimination using glecaprevir and pibrentasvir in hemodialysis patients: A multicenter study

  2019cites this paper
• Prevalence and Risk Factors for Transmission and Genotype of HCV in Iraqi Patients

  2019cites this paper
• Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy

  2019cites this paper
• Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study

  2019cites this paper
• Facilitating Patient-Centered Decision Making Around the Timing of Direct-Acting Antivirals in Patients With Hepatitis C Virus and CKD

  2019cites this paper
• Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.

  2019cites this paper
• Hepatitis C Infection Become a Common Issue Among Hemodialysis Patients in a Hemodialysis Center Jakarta, Indonesia, and Survival Comparison of Hemodialysis Patients with Hepatitis Infection between Two Hemodialysis Centers in Jakarta, Indonesia, and Penang, Malaysia

  2018cites this paper
• Ledipasvir and Sofosbuvir for untreated HCV genotype 1 infection in end stage renal disease patients: A prospective observational study

  2018cites this paper
• Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney

  2018cites this paper
• Treatment of hepatitis C in special populations

  2018cites this paper
• Hepatitis C virus–infected kidney waitlist patients: Treat now or treat later?

  2018cites this paper
• When and how can nephrologists treat hepatitis C virus infection in dialysis patients?

  2018cites this paper
• Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy

  2018cites this paper
• Hepatitis C virus infection in chronic kidney disease: paradigm shift in management

  2018cites this paper
• Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection

  2018cites this paper
• Population level outcomes and cost‐effectiveness of hepatitis C treatment pre‐ vs postkidney transplantation

  2018cites this paper
• Hepatitis C virus infection in patients with end‐stage renal disease

  2018cites this paper
• Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study

  2018cites this paper
• The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment

  2018cites this paper
• Donor Selection: Deceased Donor

  2018cites this paper
• End-Stage Renal Disease and Treatment of Hepatitis C Virus Infection

  2018cites this paper
• Sofosbuvir‐based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study

  2018cites this paper
• Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study

  2018cites this paper
• Stellungnahme der DGVS zur frühen Nutzenbewertung Elbasvir/Grazoprevir

  2018cites this paper
• The Prevalence of HCV Infection in Hemodialysis Population and Compared ELISA and PCR Methods for Detecting of HCV Infection

  2017cites this paper
• Treatment of hepatitis C virus infections in hemodialysis patients at our hospital and future prospects

  2017cites this paper
• Chronic Hemodialysis Patients; Special Group for Hepatitis C Elimination Programs in Iran

  2017influential citation
• Kidney Transplantation in the Hepatitis C Infected Recipient

  2017cites this paper
• Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.

  2017cites this paper
• Detection, Reporting, and Treatment of Hepatitis C Infections Among Hemodialysis Patients

  2017cites this paper
• Cold Plasma Technology and Reducing Surface Bacterial Counts: A Pilot Study

  2017cites this paper
• Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis

  2017cites this paper
• Use of sofosbuvir in chronic kidney disease: Is it necessary?

  2017cites this paper
• Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan

  2017cites this paper
• Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C

  2017cites this paper
• Hepatitis B and C in Kidney Transplantation

  2017cites this paper
• Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease

  2017cites this paper
• Successful treatment of chronic hepatitis C virus infection in a patient receiving daily peritoneal dialysis.

  2017cites this paper
• A COMPARATIVE STUDY OF EFFICACY BETWEEN THIRD GENERATION ELISA AND FOURTH GENERATION TRI-DOT TEST TO DETECT SEROPREVALENCE OF HEPATITIS-C INFECTION IN PATIENTS ON HAEMODIALYSIS

  2016cites this paper
• Association of aspartate aminotransferase with mortality in hemodialysis patients.

  2016cites this paper
• Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

  2016cites this paper
• Effect and Safety of Daclatasvir‐Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b ‐Infected Patients on Hemodialysis

  2016cites this paper
• Prevalence of Hepatitis B and C in dialysis : a 4-year review in Albania

  2016cites this paper
• Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment

  2016cites this paper
• Hepatitis C Virus Infection in Chronic Kidney Disease.

  2016cites this paper
• Association de sofosbuvir et daclatasvir chez un patient transplanté hépatique traité par hémodialyse

  2016cites this paper
• Prevalence and risk factors of asymptomatic hepatitis C virus infection among a sample of school aged Egyptian children.

  2016cites this paper
• [Sofosbuvir and daclatasvir combination therapy in hemodialysis patient with liver transplantation].

  2016cites this paper
• Title Association of aspartate aminotransferase with mortality in hemodialysis patients

  2016cites this paper
• Hepatitis C in hemodialysis patients.

  2015cites this paper
• Novel Hepatitis C Treatment and the Impact on Kidney Transplantation.

  2015cites this paper
• Fifty years of dialysis in Africa: challenges and progress.

  2015cites this paper
• Bacteremia in Hemodialysis Patients With Hepatitis C

  2015cites this paper
• Reappraisal of the hepatitis C virus-positive donor in solid organ transplantation

  2015cites this paper
• Shorter Waitlist Times and Improved Graft Survivals Are Observed in Patients Who Accept Hepatitis C Virus+ Renal Allografts

  2015influential citation
• Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

  2015cites this paper
• Hepatitis B and C Virus Infection in the Hemodialysis Population from Three Romanian Regions

  2015cites this paper
• Management of patients with hepatitis C infection and renal disease.

  2015cites this paper
• Prevalence, SeroconversionAnd Risk Factors Of Hepatitis B And C Infection In Haemodialysis Patients At District Hospital Of Mehsana -

  2015cites this paper
• Hepatitis C infection in hemodialysis patients: A review.

  2015cites this paper
• DIAGNOSIS OF HEPATITIS C IN CHRONIC KIDNEY DISEASE AND HEMODIALYSIS Initial testing for HCV

  2015cites this paper
• Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study

  2015cites this paper
• Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease

  2015cites this paper
• Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America.

  2015cites this paper
• Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patients

  2015cites this paper
• Prevalence of hepatitis C virus seroconversion among hemodialysis patients in Egypt

  2015cites this paper
• Valoración del estado nutricional en los diferentes estadios de la enfermedad renal crónica y su relación con el estrés oxidativo y la inflamación

  2015cites this paper
• Impact of Hepatitis C on Survival in Dialysis : Liver-Related and Cardiovascular Mortality

  2015cites this paper